Noxilizer

About:

Noxilizer provides room temperature NO2-based sterilization technology for the medical device, pharmaceutical and hospital industries.

Website: http://noxilizer.com

Twitter/X: noxilizer

Top Investors: Industrial Growth Platform

Description:

Noxilizer has a unique and superior, room temperature NO2-based sterilization technology that is revolutionizing two major sterilization markets — medical device/pharmaceutical/biotechnology manufacturing and hospitals. In the manufacturing market, Noxilizer provides sterilization services for medical devices and drug/device combination products. Noxilizer sells the RTS 360 Industrial NO2 Sterilizer to companies who sterilize products in-house and also offers contract sterilization services. In hospitals, Noxilizer is developing a system especially for sensitive, high-tech equipment used in minimally-invasive surgical procedures. Noxilizer is headquartered in Baltimore, MD with offices in the US and Japan. Noxilizer, Inc. is privately held and was founded in 2004.

Total Funding Amount:

$4.38M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)noxilizer.com

Founders:

Marie-Louise Murville

Number of Employees:

11-50

Last Funding Date:

2013-09-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai